Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. (e-MANIC)
Antimicrobial Resistance
About this trial
This is an interventional diagnostic trial for Antimicrobial Resistance focused on measuring Malaria, Diagnostic, Antimalarial, Antibiotic
Eligibility Criteria
Inclusion Criteria:
- Children from 2 to 59 months of age;
- Acute fever (axillary temperature over or equal to 37.5°) or history of fever within the past 7 days;
- Available to return for the follow-up visit at the health facility on day 7 (±2).
- Written informed consent obtained from parents/legal guardian.
Exclusion Criteria:
- Children less than 2 months or over 59 months;
- Presence of signs and symptoms of severe infections;
- Children with chronic febrile infections.
Sites / Locations
- Institut de Recherche en Sciences de la Santé-Clinical Research Unit of Nanoro
- Health District of NanoroRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Active Comparator
Control Arm
RDTs decisional Arm
e-algorithm Arm
Febrile children will be managed according to the IMCI (integrative management of childhood illnesses) and the guideline of diagnostic and treatment (GDT), which are part of the routine system existing in Burkina Faso. Treatment will be done according to the national guideline.
The clinical examination based on IMIC will be supported by two-step malaria RDT and bacterial infections RDTs. Prescription will be left to the discretion of the healthcare workers.
Artificial intelligence integrating multiple layers of clinical information such as clinical examination, signs/symptoms and medical history, and laboratory information such as outcomes of biomarkers (CRP and WBC) and pathogen specific POCT (malaria and bacterial infections) and oximetry will be developed. The e-algorithm will serve to guide the diagnostic and management of febrile infections in children from 2 to 59 months.